Search

everythinglearnresearchcommunity

for

Search:↓

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

More research is needed to determine if iron deficiency causes hair loss.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Adrenal tumors should be considered in Addison's disease if unusual results appear, with surgery as a solution.

PRP shows promise for improving hair growth in early to moderate hair loss but needs standardized methods for consistent results.

Anticoagulant therapy may cause hair loss, especially in women, and stopping the medication can lead to hair regrowth.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Low-level laser therapy seems to promote hair growth but requires more research to confirm its effectiveness.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The guideline helps diagnose and treat hidradenitis suppurativa early to improve patient outcomes.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

PRP therapy can improve hair growth in early to moderate hair loss but needs standardized methods for consistent results.

Cryotherapy and compression therapy might help prevent chemotherapy nerve damage, but more research is needed.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Testosterone's health effects are complex and not definitively understood.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

MSCs should be called "master signaling cells" because they mainly help with cell communication and tissue repair.

Botulinum toxins show promise in treating various conditions, but more research is needed for hair and scalp disorders.